TY - JOUR
T1 - [Outpatient antimicrobial drug use and antimicrobial resistance frequency in Suwa area, Nagano, Japan].
AU - Gu, Yoshiaki
AU - Okamoto, Etsuji
AU - Ohyama, Takaaki
AU - Taniguchi, Kiyosu
AU - Okabe, Nobuhiko
PY - 2011
Y1 - 2011
N2 - A cross-sectional study was conducted to determine antimicrobial use and to analyze the correlation to resistant bacteria. Records on antimicrobial prescriptions in Suwa area, Nagano prefecture, were collected from December 2009 to May 2010 from a national health insurance database system. Records on antimicrobial-resistant bacteria during the same period were collected from area hospitals. Data was then compared to data published in Europe. The target population was 31,505, or 27.1% of the total area population. More antimicrobials were prescribed in an outpatient setting rather for inpatients. Total outpatient antimicrobial use was 9.34 defined daily dose (DDD) per 1,000 subject days. Macrolides, lincosamides, and streptogramins (MLS) was the most prescribed drug group, followed by beta-lactams other than penicillin and quinolone. The quinolone-resistance rate among Escherichia coli in this area was within a predictable range based on European data, although that of macrolide-resistance among Streptococcus pneumoniae exceeded the predictable range. The health insurance system electronic database proved useful in collecting data on antimicrobial use for curbing action against antimicrobial resistance, including antimicrobial stewardship.
AB - A cross-sectional study was conducted to determine antimicrobial use and to analyze the correlation to resistant bacteria. Records on antimicrobial prescriptions in Suwa area, Nagano prefecture, were collected from December 2009 to May 2010 from a national health insurance database system. Records on antimicrobial-resistant bacteria during the same period were collected from area hospitals. Data was then compared to data published in Europe. The target population was 31,505, or 27.1% of the total area population. More antimicrobials were prescribed in an outpatient setting rather for inpatients. Total outpatient antimicrobial use was 9.34 defined daily dose (DDD) per 1,000 subject days. Macrolides, lincosamides, and streptogramins (MLS) was the most prescribed drug group, followed by beta-lactams other than penicillin and quinolone. The quinolone-resistance rate among Escherichia coli in this area was within a predictable range based on European data, although that of macrolide-resistance among Streptococcus pneumoniae exceeded the predictable range. The health insurance system electronic database proved useful in collecting data on antimicrobial use for curbing action against antimicrobial resistance, including antimicrobial stewardship.
UR - http://www.scopus.com/inward/record.url?scp=84855382944&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855382944&partnerID=8YFLogxK
U2 - 10.11150/kansenshogakuzasshi.85.494
DO - 10.11150/kansenshogakuzasshi.85.494
M3 - Article
C2 - 22117377
AN - SCOPUS:84855382944
SN - 0387-5911
VL - 85
SP - 494
EP - 500
JO - Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
JF - Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
IS - 5
ER -